China Pharma Holdings
CPHI
3 hedge funds and large institutions have $518K invested in China Pharma Holdings in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
116% more capital invested
Capital invested by funds: $240K → $518K (+$278K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more ownership
Funds ownership: 0% → 0% (+0%)
57% less funds holding
Funds holding: 7 → 3 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$29.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$7.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.11K |
| 2 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
-$2K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| 4 |
NFG
Next Financial Group
Houston,
Texas
|
-$1K |
CPHI Hedge Fund Activity: Q1 2020 in Review
3 institutional investors reported a position in China Pharma Holdings (CPHI) for Q1 2020, worth a combined $518K — up 116% from $240K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPHI and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $29.8K. The largest seller was Citadel Advisors, cutting an estimated $2.11K.
- 3 institutional investors held China Pharma Holdings (CPHI) as of Q1 2020, down from 7 in Q4 2019.
- Funds reported $518K of China Pharma Holdings stock for Q1 2020, up 116% quarter-over-quarter.
- 0 funds opened new China Pharma Holdings positions in Q1 2020 and 3 closed out, a net change of -3 holders.
- The largest China Pharma Holdings buyer in Q1 2020 was Renaissance Technologies, an estimated $29.8K added.
- The largest China Pharma Holdings seller in Q1 2020 was Citadel Advisors, an estimated $2.11K sold.
Based on aggregated 13F filings for Q1 2020.